56 Biggest Movers From Yesterday

从昨天开始的56个最大的转会

Benzinga Real-time News · 2021/11/24 05:00

Gainers

Aptevo Therapeutics Inc. (NASDAQ:APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Pasithea Therapeutics Corp. (NASDAQ:KTTA) shares surged 153.4% to close at $5.60 on Tuesday after the company announced its subsidiary Pasithea Clinics has been approved to provide esketamine nasal spray for the treatment of resistant depression in adults.
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) surged 104.8% to close at $2.56 after a Zack's Small Cap research note showed a $9 price target on the stock.
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) jumped 81.6% to settle at $7.30. HC Wainwright & Co, on Monday, initiated coverage on Vallon Pharmaceuticals with a Buy rating and announced a price target of $12.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) gained 75.9% to settle at $2.34. The company filed proxy statement for annual meeting after the market close on Monday.
iSpecimen Inc. (NASDAQ:ISPC) gained 48.5% to close at $13.19. iSpecimen shares jumped over 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
MediciNova, Inc. (NASDAQ:MNOV) surged 44% to settle at $4.42. Zacks Small-Cap Research set $27 valuation on MediciNova.
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) gained 43% to close at $5.74 after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
Esperion Therapeutics, Inc. (NASDAQ:ESPR) surged 40.7% to settle at $10.02
Sunlands Technology Group (NYSE:STG) rose 23.2% to close at $4.51 after reporting unaudited Q3 results.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) rose 22.1% to close at $7.79. Gracell Biotech said members of its senior mgmt. team, including, Chair, CEO, CFO, Chief Medical Officer intend to use personal funds to buy up to $2 million in company’s ADSs in open market over next 3 months.
Dycom Industries, Inc. (NYSE:DY) climbed 19.7% to close at $99.91 following upbeat Q3 results.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) gained 15.1% to settle at $86.50 after the company reported Q4 earnings results.
BM Technologies, Inc. (NYSE:BMTX) jumped 14.9% to close at $13.82. Chardan Capital initiated coverage on BM Technologies with a Buy rating and announced a price target of $21.
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) rose 14.7% to close at $2.88. Unicycive Therapeutics recently posted a Q3 loss of $0.37 per share.
Reliance Global Group, Inc. (NASDAQ:RELI) gained 14.7% to settle at $2.42.
Armata Pharmaceuticals Inc. (NYSE:ARMP) jumped 14.3% to settle at $5.53. The FDA recently cleared Armata Pharmaceuticals’ Investigational New Drug (IND) for Phase 1b/2a study of AP-SA02 in Staphylococcus aureus bacteremia.
QIWI plc (NASDAQ:QIWI) rose 12.7% to settle at $8.70 after the company reported better-than-expected Q3 sales results.
Movado Group, Inc. (NYSE:MOV) gained 11.7% to close at $44.58 following Q3 results.
Dollar Tree, Inc. (NASDAQ:DLTR) surged 9.2% to settle at $144.71 after the company reported better-than-expected Q3 sales results.
Kosmos Energy Ltd. (NYSE:KOS) gained 9.1% to close at $3.71.
Burlington Stores, Inc. (NYSE:BURL) surged 8.6% to close at $285.55 after the company reported better-than-expected Q3 results.
XPeng Inc. (NYSE:XPEV) jumped 8.3% to close at $51.30. XPeng reported third-quarter revenues that exceeded expectations but the loss per share trailed expectations. The company's gross margins expanded both sequentially and year-over-year.
XL Fleet Corp. (NYSE:XL) gained 6.7% to close at $4.95 after the company announced it was awarded a pilot project with the Department of Defense to prototype fuel-saving technology for tactical vehicles.
Western Digital Corporation (NASDAQ:WDC) gained 6.3% to close at $60.53. Mizuho analyst Vijay Rakesh upgraded Western Digital to Buy from Neutral with a price target of $75, up from $55, implying a 31.7% upside.
Soligenix, Inc. (NASDAQ:SNGX) rose 5.8% to settle at $0.8790. Soligenix recently posted a Q3 loss of $0.09 per share.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares rose 4.9% to close at $0.4882. The FDA has signed off Tonix Pharmaceuticals’ Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.

Check out these big penny stock gainers and losers

Losers

Society Pass Incorporated (NASDAQ:SOPA) dipped 71.3% to close at $11.18 on Tuesday. The company, earlier during the month, priced its IPO at $9 per share.
Longeveron Inc. (NASDAQ:LGVN) shares dropped 38.9% to close at $17.22 on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
Enjoy Technology, Inc. (NASDAQ:ENJY) fell 33.5% to close at $4.30. Enjoy Technology recently posted Q3 loss of $0.83 per share.
Greenland Technologies Holding Corporation (NASDAQ:GTEC) fell 28.1% to close at $8.41. Greenland Technologies will present at the upcoming Sequire Cleantech & Electric Vehicle Investor Conference to be held virtually on December 6, 2021.
Genius Sports Limited (NYSE:GENI) fell 25.3% to close at $10.19 after the company reported better-than-expected Q3 sales results and raised FY21 sales guidance above estimates.
Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 22.2% to settle at $2.25.
Entrada Therapeutics, Inc. (NASDAQ:TRDA) dipped 20.6% to close at $24.13. Goldman Sachs initiated coverage on Entrada Therapeutics with a Neutral rating and announced a price target of $29.
Vinco Ventures, Inc. (NASDAQ:BBIG) declined 20% to close at $3.13. Vinco Ventures reported a third-quarter FY21 sales decline of 11.5% year-on-year, to $2.23 million.
Local Bounti Corp. (NYSE:LOCL) dipped 19.1% to settle at $8.01.
Aurora Innovation, Inc. (NASDAQ:AUR) fell 18.7% to close at $12.15.
Sarcos Technology and Robotics Corporation (NASDAQ:STRC) dropped 18% to settle at $6.58. Credit Suisse initiated coverage on Sarcos Technology with a Neutral rating and announced a price target of $9.
Benson Hill, Inc. (NYSE:BHIL) dipped 17.6% to settle at $6.10. Goldman Sachs initiated coverage on Benson Hill with a Neutral rating and announced a price target of $9.
Science 37 Holdings, Inc. (NASDAQ:SNCE) fell 17.1% to close at $9.43.
PainReform Ltd. (NASDAQ:PRFX) fell 17% to close at $1.91. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.
Femasys Inc. (NASDAQ:FEMY) dipped 16.8% to settle at $4.06.
Design Therapeutics, Inc. (NASDAQ:DSGN) fell 16.3% to close at $17.00.
Momentus Inc. (NASDAQ:MNTS) dropped 15.5% to settle at $6.88.
Tyra Biosciences, Inc. (NASDAQ:TYRA) declined 15.5% to settle at $19.34.
Zoom Video Communications, Inc. (NASDAQ:ZM) fell 14.7% to close at $206.64. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. B of A Securities downgraded Zoom from Buy to Neutral and lowered the price target from $385 to $270.
GameStop Corp. (NYSE:GME) dropped 13.6% to settle at $213.90 amid overall weakness as a rise in yields weighs on stocks.
Abercrombie & Fitch Co. (NYSE:ANF) fell 12.6% to close at $41.12 after the company reported Q3 earnings results.
Best Buy Co., Inc. (NYSE:BBY) fell 12.3% to close at $121.01 after the company reported third-quarter FY22 Enterprise sales growth of 0.5% year-on-year, to $11.91 billion, beating the analyst consensus of $11.56 billion. Enterprise comparable sales increased 1.6% versus 23.0% growth last year.
The Lovesac Company (NASDAQ:LOVE) fell 10.7% to close at $72.34. Andrew R Heyer, Insider at Lovesac, made a large insider sell on November 19, according to a new SEC filing.
Urban Outfitters, Inc. (NASDAQ:URBN) fell 9.3% to close at $33.80. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) fell 8.4% to close at $0.8068. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.
Relay Therapeutics, Inc. (NASDAQ:RLAY) fell 7.8% to close at $31.61.
Central Garden & Pet Company (NASDAQ:CENTA) dropped 6.3% to close at $46.59 following Q4 results.
Hibbett, Inc. (NASDAQ:HIBB) dropped 5.3% to close at $94.41. Hibbett is expected to issue its Q3 earnings release before the market opens on December 3, 2021.
DICK'S Sporting Goods, Inc. (NYSE:DKS) declined 4.1% to close at $134.55 following Q3 results.

Gainers

赢家

Aptevo Therapeutics Inc. (NASDAQ:APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Pasithea Therapeutics Corp. (NASDAQ:KTTA) shares surged 153.4% to close at $5.60 on Tuesday after the company announced its subsidiary Pasithea Clinics has been approved to provide esketamine nasal spray for the treatment of resistant depression in adults.
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) surged 104.8% to close at $2.56 after a Zack's Small Cap research note showed a $9 price target on the stock.
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) jumped 81.6% to settle at $7.30. HC Wainwright & Co, on Monday, initiated coverage on Vallon Pharmaceuticals with a Buy rating and announced a price target of $12.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) gained 75.9% to settle at $2.34. The company filed proxy statement for annual meeting after the market close on Monday.
iSpecimen Inc. (NASDAQ:ISPC) gained 48.5% to close at $13.19. iSpecimen shares jumped over 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
MediciNova, Inc. (NASDAQ:MNOV) surged 44% to settle at $4.42. Zacks Small-Cap Research set $27 valuation on MediciNova.
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) gained 43% to close at $5.74 after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
Esperion Therapeutics, Inc. (NASDAQ:ESPR) surged 40.7% to settle at $10.02
Sunlands Technology Group (NYSE:STG) rose 23.2% to close at $4.51 after reporting unaudited Q3 results.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) rose 22.1% to close at $7.79. Gracell Biotech said members of its senior mgmt. team, including, Chair, CEO, CFO, Chief Medical Officer intend to use personal funds to buy up to $2 million in company’s ADSs in open market over next 3 months.
Dycom Industries, Inc. (NYSE:DY) climbed 19.7% to close at $99.91 following upbeat Q3 results.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) gained 15.1% to settle at $86.50 after the company reported Q4 earnings results.
BM Technologies, Inc. (NYSE:BMTX) jumped 14.9% to close at $13.82. Chardan Capital initiated coverage on BM Technologies with a Buy rating and announced a price target of $21.
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) rose 14.7% to close at $2.88. Unicycive Therapeutics recently posted a Q3 loss of $0.37 per share.
Reliance Global Group, Inc. (NASDAQ:RELI) gained 14.7% to settle at $2.42.
Armata Pharmaceuticals Inc. (NYSE:ARMP) jumped 14.3% to settle at $5.53. The FDA recently cleared Armata Pharmaceuticals’ Investigational New Drug (IND) for Phase 1b/2a study of AP-SA02 in Staphylococcus aureus bacteremia.
QIWI plc (NASDAQ:QIWI) rose 12.7% to settle at $8.70 after the company reported better-than-expected Q3 sales results.
Movado Group, Inc. (NYSE:MOV) gained 11.7% to close at $44.58 following Q3 results.
Dollar Tree, Inc. (NASDAQ:DLTR) surged 9.2% to settle at $144.71 after the company reported better-than-expected Q3 sales results.
Kosmos Energy Ltd. (NYSE:KOS) gained 9.1% to close at $3.71.
Burlington Stores, Inc. (NYSE:BURL) surged 8.6% to close at $285.55 after the company reported better-than-expected Q3 results.
XPeng Inc. (NYSE:XPEV) jumped 8.3% to close at $51.30. XPeng reported third-quarter revenues that exceeded expectations but the loss per share trailed expectations. The company's gross margins expanded both sequentially and year-over-year.
XL Fleet Corp. (NYSE:XL) gained 6.7% to close at $4.95 after the company announced it was awarded a pilot project with the Department of Defense to prototype fuel-saving technology for tactical vehicles.
Western Digital Corporation (NASDAQ:WDC) gained 6.3% to close at $60.53. Mizuho analyst Vijay Rakesh upgraded Western Digital to Buy from Neutral with a price target of $75, up from $55, implying a 31.7% upside.
Soligenix, Inc. (NASDAQ:SNGX) rose 5.8% to settle at $0.8790. Soligenix recently posted a Q3 loss of $0.09 per share.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares rose 4.9% to close at $0.4882. The FDA has signed off Tonix Pharmaceuticals’ Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.

Aptevo治疗公司纳斯达克(APVO：APVO)股价跳涨162.8%，收于17.03美元，此前该公司宣布了评估APVO436治疗急性髓系白血病的1b期扩大试验的最新临床结果。
帕西娅治疗公司(Pasithea Treateutics Corp.)纳斯达克(Sequoia Capital：KTTA)股价周二飙升153.4%，收于5.6美元，此前该公司宣布其子公司帕西西娅诊所(Pasithea Clinics)已获准提供埃斯氯胺酮鼻喷雾剂，用于治疗成人难治性抑郁症。
夸里根治疗公司(Qualigen Treateutics，Inc.)纳斯达克(Sequoia Capital：QLGN)暴涨104.8%，收于2.56美元，此前Zack‘s Small Cap研究报告显示该股目标价为9美元。
瓦隆制药公司纳斯达克(Sequoia Capital：VLON)跳涨81.6%，收于7.3美元。周一，HC Wainwright&Co以买入评级启动了对Vallon PharmPharmticals的覆盖，并宣布目标价为12美元。
Petros制药公司纳斯达克(Starbucks：PTPI)上涨75.9%，收于2.34美元。周一收盘后，该公司提交了年度会议的委托书。
ISpecimen Inc.纳斯达克(Sequoia Capital：ISPC)上涨48.5%，收于13.19美元。周一，在宣布签约支持新冠肺炎的新的高级研究后，iSpecimen的股价跃升了超过80%，该研究旨在寻求对微博的传播性、变种、结果和测试在多个人群群体中的有效性的见解。
MediciNova，Inc.纳斯达克(Sequoia Capital：MNOV)暴涨44%，收于4.42美元。Zacks Small-Cap Research对MediciNova的估值为27美元。
克拉鲁斯治疗控股公司(Clarus Treateutics Holdings，Inc.)纳斯达克(Kleiner Perkins Caufield&Byers)(CRXT：CRXT)股价上涨43%，收于5.74美元，此前该公司获得一项名为“口服睾酮酯配方和治疗睾酮缺乏症方法”的美国专利。
Esperion治疗公司纳斯达克(Sequoia Capital：ESPR)暴涨40.7%，结算价报10.02美元
尚德机构(纽约证券交易所代码：STG)股价上涨23.2%，收于4.51美元，此前该公司公布了未经审计的第三季度业绩。
亘喜生物(Sequoia Capital Inc.)纳斯达克(GRCL：GRCL)上涨22.1%，收于7.79美元。Gracell Biotech表示，其高级管理人员。包括董事长、首席执行官、首席财务官、首席医疗官在内的团队打算在未来3个月内使用个人资金在公开市场购买最多200万美元的公司美国存托凭证(ADS)。
戴姆康工业公司(Dycom Industries，Inc.)纽约证券交易所(NYSE：DY)股价上涨19.7%，收于99.91美元，第三季度业绩乐观。
Enanta制药公司纳斯达克(Kleiner Perkins Caufield&Byers)股价上涨15.1%，收于86.5美元，此前该公司公布了第四季度收益业绩。
BM技术公司(纽约证券交易所代码：BMTX)跳涨14.9%，收于13.82美元。Chardan Capital以买入评级启动了对BM Technologies的报道，并宣布目标价为21美元。
Unicycive治疗公司纳斯达克(Sequoia Capital：UNCY)上涨14.7%，收报2.88美元。Unicycive Treeutics最近公布第三季度每股亏损0.37美元。
信实全球集团有限公司(Reliance Global Group，Inc.)纳斯达克(Sequoia Capital：REI)上涨14.7%，收于2.42美元。
阿玛塔制药公司(Armata PharmPharmticals Inc.)(纽约证券交易所代码：ARMP)跃升14.3%，收于5.53美元。FDA最近批准了Armata制药公司的研究新药(IND)用于AP-SA02治疗金黄色葡萄球菌菌血症的1b/2a阶段研究。
QIWI plc纳斯达克(Sequoia Capital：QIWI)股价上涨12.7%，收于8.70美元，此前该公司公布了好于预期的第三季度销售业绩。
摩瓦多集团(Movado Group，Inc.)(纽约证券交易所代码：MOV)在第三季度业绩公布后上涨11.7%，收于44.58美元。
美元树公司纳斯达克(Starbucks：DLTR)股价飙升9.2%，收于144.71美元，此前该公司公布了好于预期的第三季度销售业绩。
科斯莫斯能源有限公司(纽约证券交易所代码：KOS)上涨9.1%，收于3.71美元。
伯灵顿百货公司(Burlington Stores，Inc.)(纽约证券交易所股票代码：BURL)暴涨8.6%，收于285.55美元，此前该公司公布了好于预期的第三季度业绩。
小鹏汽车-W公司(纽约证券交易所代码：XPEV)跳涨8.3%，收于51.30美元。小鹏汽车-W报告第三季度营收超出预期，但每股亏损低于预期。该公司的毛利率环比和同比均有所增长。
XL舰队公司纽约证券交易所(NYSE：XL)股价上涨6.7%，收于4.95美元，此前该公司宣布获得国防部的一个试验项目，用于战术车辆的节油技术原型。
西部数据公司纳斯达克(Starbucks：WDC)上涨6.3%，收于60.53美元。瑞穗(Mizuho)分析师维杰·拉凯什(Vijay Rakesh)将西部数据的评级从55美元上调至75美元，这意味着西部数据将上涨31.7%。
Soligix，Inc.纳斯达克(SNGX：SNGX)上涨5.8%，收于0.8790美元。Soligix最近公布第三季度每股亏损0.09美元。
东尼克斯制药控股公司(Tonix PharmPharmticals Holding Corp.)纳斯达克(Starbucks：TNXP)股价上涨4.9%，收于0.4882美元。FDA已经批准了Tonix制药公司的研究新药(IND)申请，启动了治疗偏头痛的TNX-1900的第二阶段研究。

Check out these big penny stock gainers and losers

看看这些微不足道的股票赢家和输家

Losers

失败者

Society Pass Incorporated (NASDAQ:SOPA) dipped 71.3% to close at $11.18 on Tuesday. The company, earlier during the month, priced its IPO at $9 per share.
Longeveron Inc. (NASDAQ:LGVN) shares dropped 38.9% to close at $17.22 on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
Enjoy Technology, Inc. (NASDAQ:ENJY) fell 33.5% to close at $4.30. Enjoy Technology recently posted Q3 loss of $0.83 per share.
Greenland Technologies Holding Corporation (NASDAQ:GTEC) fell 28.1% to close at $8.41. Greenland Technologies will present at the upcoming Sequire Cleantech & Electric Vehicle Investor Conference to be held virtually on December 6, 2021.
Genius Sports Limited (NYSE:GENI) fell 25.3% to close at $10.19 after the company reported better-than-expected Q3 sales results and raised FY21 sales guidance above estimates.
Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 22.2% to settle at $2.25.
Entrada Therapeutics, Inc. (NASDAQ:TRDA) dipped 20.6% to close at $24.13. Goldman Sachs initiated coverage on Entrada Therapeutics with a Neutral rating and announced a price target of $29.
Vinco Ventures, Inc. (NASDAQ:BBIG) declined 20% to close at $3.13. Vinco Ventures reported a third-quarter FY21 sales decline of 11.5% year-on-year, to $2.23 million.
Local Bounti Corp. (NYSE:LOCL) dipped 19.1% to settle at $8.01.
Aurora Innovation, Inc. (NASDAQ:AUR) fell 18.7% to close at $12.15.
Sarcos Technology and Robotics Corporation (NASDAQ:STRC) dropped 18% to settle at $6.58. Credit Suisse initiated coverage on Sarcos Technology with a Neutral rating and announced a price target of $9.
Benson Hill, Inc. (NYSE:BHIL) dipped 17.6% to settle at $6.10. Goldman Sachs initiated coverage on Benson Hill with a Neutral rating and announced a price target of $9.
Science 37 Holdings, Inc. (NASDAQ:SNCE) fell 17.1% to close at $9.43.
PainReform Ltd. (NASDAQ:PRFX) fell 17% to close at $1.91. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.
Femasys Inc. (NASDAQ:FEMY) dipped 16.8% to settle at $4.06.
Design Therapeutics, Inc. (NASDAQ:DSGN) fell 16.3% to close at $17.00.
Momentus Inc. (NASDAQ:MNTS) dropped 15.5% to settle at $6.88.
Tyra Biosciences, Inc. (NASDAQ:TYRA) declined 15.5% to settle at $19.34.
Zoom Video Communications, Inc. (NASDAQ:ZM) fell 14.7% to close at $206.64. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. B of A Securities downgraded Zoom from Buy to Neutral and lowered the price target from $385 to $270.
GameStop Corp. (NYSE:GME) dropped 13.6% to settle at $213.90 amid overall weakness as a rise in yields weighs on stocks.
Abercrombie & Fitch Co. (NYSE:ANF) fell 12.6% to close at $41.12 after the company reported Q3 earnings results.
Best Buy Co., Inc. (NYSE:BBY) fell 12.3% to close at $121.01 after the company reported third-quarter FY22 Enterprise sales growth of 0.5% year-on-year, to $11.91 billion, beating the analyst consensus of $11.56 billion. Enterprise comparable sales increased 1.6% versus 23.0% growth last year.
The Lovesac Company (NASDAQ:LOVE) fell 10.7% to close at $72.34. Andrew R Heyer, Insider at Lovesac, made a large insider sell on November 19, according to a new SEC filing.
Urban Outfitters, Inc. (NASDAQ:URBN) fell 9.3% to close at $33.80. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) fell 8.4% to close at $0.8068. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.
Relay Therapeutics, Inc. (NASDAQ:RLAY) fell 7.8% to close at $31.61.
Central Garden & Pet Company (NASDAQ:CENTA) dropped 6.3% to close at $46.59 following Q4 results.
Hibbett, Inc. (NASDAQ:HIBB) dropped 5.3% to close at $94.41. Hibbett is expected to issue its Q3 earnings release before the market opens on December 3, 2021.
DICK'S Sporting Goods, Inc. (NYSE:DKS) declined 4.1% to close at $134.55 following Q3 results.

协会通行证有限公司纳斯达克(Sequoia Capital：SOPA)周二下跌71.3%，收于11.18美元。本月早些时候，该公司将IPO定价为每股9美元。
隆格韦隆公司(Longeveron Inc.)纳斯达克股价周二下跌38.9%，收于17.22美元。该公司上周宣布，FDA授予Lomecel-B治疗左心发育不良综合征的罕见儿科疾病称号。
乐享科技有限公司纳斯达克(Sequoia Capital：ENJY)跌33.5%，收于4.3美元。愉悦科技最近公布第三季度每股亏损0.83美元。
格陵兰技术控股公司纳斯达克(GTEC：GTEC)跌28.1%，收报8.41美元。格陵兰技术公司将出席即将于2021年12月6日举行的Sequire Cleantech&电动汽车投资者大会(Sequire Cleantech&Electric Vehicle Investor Conference)。
天才体育有限公司(纽约证券交易所代码：GENI)股价下跌25.3%，收于10.19美元，此前该公司公布了好于预期的第三季度销售业绩，并上调了21财年的销售指引，高于预期。
格罗姆社会企业公司纳斯达克(Starbucks：Grom)下跌22.2%，收于2.25美元。
Entrada治疗公司纳斯达克(Sequoia Capital：TRDA)下跌20.6%，收于24.13美元。高盛(Goldman Sachs)以中性评级启动了对Entrada治疗公司的报道，并宣布目标价为29美元。
Vinco Ventures，Inc.纳斯达克(Sequoia Capital：BBIG)下跌20%，收于3.13美元。Vinco Ventures报告21财年第三季度销售额同比下降11.5%，至223万美元。
当地邦蒂公司(Local Bounti Corp.)(纽约证券交易所代码：Locl)下跌19.1%，收于8.01美元。
奥罗拉创新公司纳斯达克(Starbucks：AUR)下跌18.7%，收于12.15美元。
萨科斯技术和机器人公司纳斯达克(Sequoia Capital：STRC)下跌18%，收于6.58美元。瑞士信贷(Credit Suisse)以中性评级启动了对Sarcos Technology的覆盖，并宣布目标价为9美元。
本森·希尔公司(Benson Hill，Inc.)(纽约证券交易所代码：BHIL)下跌17.6%，收于6.10美元。高盛(Goldman Sachs)以中性评级启动了对本森山(Benson Hill)的报道，并宣布目标价为9美元。
科学37控股公司纳斯达克(Starbucks：SNCE)下跌17.1%，收于9.43美元。
画改有限公司纳斯达克(Starbucks：PRFX)下跌17%，收于1.91美元。PainReform最近公布，在截至9月1日的9个月中，净亏损550万美元。30,2021年。
Femasys Inc.纳斯达克(Weibo：FAMY)下跌16.8%，收于4.06美元。
设计治疗公司纳斯达克(DSGN：DSGN)下跌16.3%，收于17.00美元。
Momentus Inc.纳斯达克(Sequoia Capital：MNTS)下跌15.5%，收于6.88美元。
泰拉生物科学公司纳斯达克(TYRA：TYRA)下跌15.5%，收于19.34美元。
Zoom Video Communications，Inc.纳斯达克(Sequoia Capital：ZM)下跌14.7%，收于206.64美元。Zoom Video周一公布第三季业绩优于预期。该公司报告称，在过去12个月中贡献超过10万美元的客户总数为2,507人，同比增长94%。B of A Securities将Zoom评级从买入下调至中性，目标价从385美元下调至270美元。
GameStop公司(纽约证券交易所股票代码：GME)下跌13.6%，收于213.90美元，整体疲软，收益率上升令股市承压。
Abercrombie&Fitch Co.(纽约证券交易所股票代码：ANF)下跌12.6%，收于41.12美元，此前该公司公布了第三季度收益业绩。
百思买(Best Buy Co.，Inc.)BBY(纽约证券交易所股票代码：BBY)下跌12.3%，收于121.01美元，此前该公司公布22财年第三季度企业销售额同比增长0.5%，至19.1亿美元，超出分析师一致预期的15.6亿美元。企业可比销售额增长了1.6%，而去年的增幅为23.0%。
洛维萨克公司纳斯达克(Weibo：LOVE)跌10.7%，收报72.34美元。一份新的美国证券交易委员会备案文件显示，洛维萨克的内部人士安德鲁·R·海耶(Andrew R Heyer)在11月19日进行了一次大规模的内幕出售。
城市用品公司(Urban Outfitters，Inc.)纳斯达克(Sequoia Capital：URBN)下跌9.3%，收于33.8美元。Urban Outfitters公布了第三季度乐观的收益和销售业绩。该季度其同店销售额同比增长14.6%。
亚达米斯制药公司纳斯达克(Sequoia Capital：ADMP)下跌8.4%，收于0.8068美元。Adamis制药公司表示，截至9月1日的9个月的销售额。302021年的收入为340万美元。
接力治疗公司(Relay Treeutics，Inc.)纳斯达克(Sequoia Capital：RLAY)下跌7.8%，收于31.61美元。
中央花园宠物公司纳斯达克(Kleiner Perkins Caufield&Byers)第四季度财报公布后，股价下跌6.3%，收于46.59美元。
Hibbett，Inc.纳斯达克(Standard Chartered Bank：HIBB)下跌5.3%，收于94.41美元。Hibbett预计将在2021年12月3日市场开盘前发布第三季度收益报告。
迪克体育用品公司(纽约证券交易所股票代码：DKS)在第三季度业绩公布后下跌4.1%，收于134.55美元。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

56 Biggest Movers From Yesterday

56 Biggest Movers From Yesterday

Gainers

Losers

Gainers

赢家

Losers

失败者

风险及免责提示

声明